Acelity Revenue and Competitors
Estimated Revenue & Valuation
- Acelity's estimated annual revenue is currently $1.1B per year.
- Acelity's estimated revenue per employee is $401,600
- Acelity's total funding is $2M.
- Acelity's current valuation is $6.7B. (May 2019)
Employee Data
- Acelity has 2808 Employees.
- Acelity grew their employee count by -3% last year.
Acelity's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr. Facilities Manager | Reveal Email/Phone |
2 | Territory Business Manager | Reveal Email/Phone |
3 | Healthcare Intake Specialist | Reveal Email/Phone |
4 | Account Executive | Reveal Email/Phone |
Acelity Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $18.6M | 74 | 21% | N/A | N/A |
#2 | $37.7M | 150 | -7% | N/A | N/A |
#3 | $1.4M | 11 | -31% | $5.1M | N/A |
#4 | $49.7M | 198 | 14% | N/A | N/A |
#5 | $1.3M | 10 | 0% | $6.3M | N/A |
#6 | $60.7M | 242 | N/A | N/A | N/A |
#7 | $28.1M | 112 | 8% | N/A | N/A |
#8 | $5.5M | 22 | -19% | N/A | N/A |
#9 | $3M | 12 | -20% | N/A | N/A |
#10 | $10.3M | 41 | N/A | N/A | N/A |
What Is Acelity?
Acelity is a global wound care and regenerative medicine company created by uniting the strengths of three companies, Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. We are committed to advancing the science of healing and restoring people’s lives. Available in more than 75 countries, the innovative and complementary Acelity product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs more than 5,500 people around the world. We believe in enabling better futures for everyone.
keywords:N/A$2M
Total Funding
2808
Number of Employees
$1.1B
Revenue (est)
-3%
Employee Growth %
$6.7B
Valuation
N/A
Accelerator
Acelity News
3M Healthcare, BMG Pharma, ConvaTec Inc, Acelity LP, Alliqua Biomedical, Integra Life Sciences, Intermed Pharmaceuticals, Molnlycke Health Care...
Acelity L.P. Inc., Smith & Nephew plc, Baxter International Inc., Coloplast A/S, Medtronic plc, M lnlycke Health Care AB, Ethicon Inc.,...
Acelity L.P. Inc, Smith & Nephew, B. Braun Melsungen AG, ConvaTec Group, Coloplast , Paul Hartmann, Mölnlycke Health Care,...
3M (NYSE: MMM) is to acquire global medical technology company Acelity, Inc., and its KCI subsidiaries worldwide, for a total enterprise value of approximately $6.7 billion. The seller was a consortium comprised of funds advised by Apax Partners (the Apax Funds), together with controlled affili ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $927.4M | 3011 | 6% | N/A |
#2 | $452.8M | 3171 | 7% | N/A |
#3 | $1240.2M | 3212 | 7% | $14.6M |
#4 | $666.7M | 3284 | N/A | N/A |
#5 | $1340M | 3746 | 7% | $10M |